Inventor · disambiguated record
Stephen Hitchcock
Also filed as: HITCHCOCK STEPHEN · HITCHCOCK STEPHEN A · HITCHCOCK STEPHEN ANDREW
47 granted patents·12 pending applications·184 citations·filing 1999–2020
98Inventor score
Top patents by PatentIndex Score
59 records- 0192US9556130B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 31, 2017·9 cites·18 claims
- 0291US11173161B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·2 cites·33 claims
- 0391US10159677B24-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 25, 2018·7 cites·32 claims
- 0490US9770450B24-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·7 cites·32 claims
- 0589US7538114B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2007·Granted May 26, 2009·14 cites·43 claims
- 0688US9303045B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Apr 5, 2016·7 cites·11 claims
- 0787US10561662B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 18, 2020·4 cites·32 claims
- 0887US9012447B25-HT3 receptor antagonistsENVOY THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·8 cites·15 claims
- 0986US9346829B25-HT3 receptor antagonistsHITCHCOCK STEPHEN·Filed 2015·Granted May 24, 2016·5 cites·2 claims
- 1086US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 1185US9670229B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·3 cites·11 claims
- 1285US7989461B2Substituted quinazolinamine compounds for the treatment of cancerAMGEN INC·Filed 2006·Granted Aug 2, 2011·9 cites·14 claims
- 1384US9770452B2Quinoxaline derivatives as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·4 cites·22 claims
- 1484US9296698B2Amino heteroaryl compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2010·Granted Mar 29, 2016·5 cites·14 claims
- 1583US7595339B2CB1 modulator compoundsLILLY CO ELI·Filed 2007·Granted Sep 29, 2009·6 cites·2 claims
- 1680US9487526B2Quinoxaline derivatives as GPR6 modulatorsENVOY THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·5 cites·21 claims
- 1777US10179783B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 15, 2019·2 cites·8 claims
- 1877US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 1975US10077266B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 18, 2018·1 cites·11 claims
- 2074US6069238ASpirocyclic C-glycosidesLILLY CO ELI·Filed 1999·Granted May 30, 2000·39 cites·7 claims
- 2173US8440674B2Substituted pyrimidine compounds as RAF inhibitors and methods of useDE MORIN FRENEL F·Filed 2011·Granted May 14, 2013·4 cites·12 claims
- 2272US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 2371US9708313B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsBROWN JASON W·Filed 2015·Granted Jul 18, 2017·1 cites·15 claims
- 2470US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 2569US10738046B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 11, 2020·0 cites·21 claims
- 2669US7326731B2Muscarinic agonistsLILLY CO ELI·Filed 2002·Granted Feb 5, 2008·4 cites·14 claims
- 2768US10597392B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICAL CORPORATION LTD·Filed 2018·Granted Mar 24, 2020·1 cites·11 claims
- 2868US10407443B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 2968US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 3068US7265246B2Indane derivates as muscarinic receptor agonistsLILLY CO ELI·Filed 2004·Granted Sep 4, 2007·3 cites·15 claims
- 3166US8258306B2Glycine transporter-1 inhibitorsHITCHCOCK STEPHEN A·Filed 2008·Granted Sep 4, 2012·1 cites·11 claims
- 3265US10125145B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 3365US8183244B2Glycine transporter-1 inhibitorsHITCHCOCK STEPHEN·Filed 2009·Granted May 22, 2012·0 cites·35 claims
- 3463US2018072758A15ht3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 3562US9695195B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 4, 2017·0 cites·9 claims
- 3662US9663476B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·0 cites·20 claims
- 3761US10406157B2Tetrahydropyridopyrazine modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·28 claims
- 3860US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 3956US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 4056US6653281B1Ring modified cyclic peptide analogsLILLY CO ELI·Filed 1999·Granted Nov 25, 2003·16 cites·20 claims
- 4152US2011166132A1Gamma Secretase ModulatorsAMGEN INC·Filed 2008·Application pending·0 cites
- 4251US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 4351US2009062291A1Phosphodiesterase 10 inhibitorsHU ESSA·Filed 2008·Application pending·0 cites
- 4451US2009062277A1Phosphodiesterase 10 inhibitorsHU ESSA·Filed 2008·Application pending·0 cites
- 4550US6939946B2Ring modified cyclic peptide analogsLILLY CO ELI·Filed 2003·Granted Sep 6, 2005·0 cites·18 claims
- 4646US8552181B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2012·Granted Oct 8, 2013·0 cites·12 claims
- 4746US7378447B2Muscarinic agonistsLILLY CO ELI·Filed 2004·Granted May 27, 2008·0 cites·12 claims
- 4846US2006154922A1Muscarinic agonistsELILILLY AND COMPANY·Filed 2004·Application pending·0 cites
- 4943US8633315B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2012·Granted Jan 21, 2014·0 cites·10 claims
- 5043US8163766B2Beta-secretase modulators and methods of useZHONG WENGE·Filed 2010·Granted Apr 24, 2012·0 cites·10 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Hitchcock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →